Cargando…
Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol
BACKGROUND: Multiple sclerosis (MS) is an inflammatory and degenerative disease of the central nervous system with an increasing worldwide prevalence. Since 1993, more than 15 disease-modifying immunotherapies (DMTs) have been licenced and have shown moderate efficacy in clinical trials. Based on th...
Autores principales: | Lehnert, Thomas, Röver, Christian, Köpke, Sascha, Rio, Jordi, Chard, Declan, Fittipaldo, Andrea V., Friede, Tim, Heesen, Christoph, Rahn, Anne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250266/ https://www.ncbi.nlm.nih.gov/pubmed/35778721 http://dx.doi.org/10.1186/s13643-022-01997-2 |
Ejemplares similares
-
Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2015) -
Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy
por: Almouzain, Lubna, et al.
Publicado: (2021) -
Risk knowledge of people with relapsing-remitting multiple sclerosis – Results of an international survey
por: Giordano, Andrea, et al.
Publicado: (2018) -
Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2021) -
Correction to: Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial
por: Rahn, Anne Christin, et al.
Publicado: (2021)